Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure.

Highlighted with 59 tables and 54 figures, this 141-page report “Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Country.

Based on Vaccine Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Live/Attenuated Vaccines

• Inactivated Vaccines

• Subunit Vaccines

• Toxoid Vaccines

• Conjugate Vaccines

• mRNA Vaccines

• Recombinant Vector Vaccines

• Other Vaccines

Based on Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pneumococcal Disease

• Poliovirus

• Hepatitis

• Influenza

• Measles, Mumps, and Rubella (MMR)

• Varicella

• Human Papilloma Virus

• COVID-19

• Other Diseases

By Administration, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Intramuscular Route

• Subcutaneous Route

• Oral Route

• Intravenous Injection

• Other Administration Routes

By Patient, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pediatric Vaccines

o Pneumococcal

o Measles, Mumps, and Rubella (MMR)

o Varicella

o Hepatitis

o Poliovirus

o Haemophilus Influenzae B (HIB)

o Other Diseases

• Adult Vaccines

o Influenza

o Cervical Cancer

o Hepatitis

o Zoster

o Other Diseases

Geographically, the following national/local markets are fully investigated:

• Japan

• China

• South Korea

• Australia

• India

• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Vaccine Type, Disease, and Administration over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

AstraZeneca plc

Bavarian Nordic A/S

China National Biotec Group Company Ltd.

CSL Ltd.

Daiichi Sankyo Co. Ltd

Emergent BioSolutions Inc.

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co.

Moderna Inc.

Novavax, Inc.

Pfizer Inc.

Sanofi SA

Takeda Pharmaceutical Co. Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 25

2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27

2.2 Major Growth Drivers 31

2.3 Market Restraints and Challenges 37

2.4 Emerging Opportunities and Market Trends 40

2.5 Porter’s Fiver Forces Analysis 44

3 Segmentation of Asia Pacific Market by Vaccine Type 48

3.1 Market Overview by Vaccine Type 48

3.2 Live/Attenuated Vaccines 50

3.3 Inactivated Vaccines 51

3.4 Subunit Vaccines 52

3.5 Toxoid Vaccines 53

3.6 Conjugate Vaccines 54

3.7 mRNA Vaccines 55

3.8 Recombinant Vector Vaccines 56

3.9 Other Vaccines 57

4 Segmentation of Asia Pacific Market by Disease 58

4.1 Market Overview by Disease 58

4.2 Pneumococcal Disease 60

4.3 Poliovirus 61

4.4 Hepatitis 62

4.5 Influenza 63

4.6 Measles, Mumps, and Rubella (MMR) 64

4.7 Varicella 65

4.8 Human Papilloma Virus 66

4.9 COVID-19 67

4.10 Other Diseases 68

5 Segmentation of Asia Pacific Market by Administration 69

5.1 Market Overview by Administration 69

5.2 Intramuscular Route 71

5.3 Subcutaneous Route 72

5.4 Oral Route 73

5.5 Intravenous Injection 74

5.6 Other Administration Routes 75

6 Segmentation of Asia Pacific Market by Patient 76

6.1 Market Overview by Patient 76

6.2 Pediatric Vaccines 78

6.3 Adult Vaccines 80

7 Asia-Pacific Market 2022-2032 by Country 82

7.1 Overview of Asia-Pacific Market 82

7.2 Japan 85

7.3 China 89

7.4 Australia 93

7.5 India 96

7.6 South Korea 99

7.7 Rest of APAC Region 102

8 Competitive Landscape 104

8.1 Overview of Key Vendors 104

8.2 New Product Launch, Partnership, Investment, and M&A 107

8.3 Company Profiles 108

AstraZeneca plc 108

Bavarian Nordic A/S 110

China National Biotec Group Company Ltd. 113

CSL Ltd. 115

Daiichi Sankyo Co. Ltd 117

Emergent BioSolutions Inc. 119

GlaxoSmithKline plc 121

Johnson & Johnson 125

Merck & Co. 127

Moderna Inc. 129

Novavax, Inc. 130

Pfizer Inc. 132

Sanofi SA 136

Takeda Pharmaceutical Co. Ltd. 139

RELATED REPORTS 141

List of Tables:

Table 1. Snapshot of Asia Pacific Preventive Vaccines Market in Balanced Perspective, 2022-2032 18

Table 2. World Economic Outlook, 2021-2031 23

Table 3. World Economic Outlook, 2021-2023 24

Table 4. Scenarios for Economic Impact of Ukraine Crisis 28

Table 5. World Health Spending by Region, $ bn, 2013-2020 36

Table 6. Main Product Trends and Market Opportunities in Asia Pacific Preventive Vaccines Market 40

Table 7. Asia Pacific Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 48

Table 8. Asia Pacific Preventive Vaccines Market by Disease, 2022-2032, $ mn 58

Table 9. Asia Pacific Preventive Vaccines Market by Administration, 2022-2032, $ mn 69

Table 10. Asia Pacific Preventive Vaccines Market by Patient, 2022-2032, $ mn 76

Table 11. Asia Pacific Preventive Vaccines Market: Pediatric Vaccines by Disease, 2022-2032, $ mn 79

Table 12. Asia Pacific Preventive Vaccines Market: Adult Vaccines by Disease, 2022-2032, $ mn 81

Table 13. APAC Preventive Vaccines Market by Country, 2022-2032, $ mn 83

Table 14. Japan Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 87

Table 15. Japan Preventive Vaccines Market by Disease, 2022-2032, $ mn 87

Table 16. Japan Preventive Vaccines Market by Administration, 2022-2032, $ mn 88

Table 17. China Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 90

Table 18. China Preventive Vaccines Market by Disease, 2022-2032, $ mn 90

Table 19. China Preventive Vaccines Market by Administration, 2022-2032, $ mn 92

Table 20. Australia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 94

Table 21. Australia Preventive Vaccines Market by Disease, 2022-2032, $ mn 94

Table 22. Australia Preventive Vaccines Market by Administration, 2022-2032, $ mn 95

Table 23. India Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 97

Table 24. India Preventive Vaccines Market by Disease, 2022-2032, $ mn 97

Table 25. India Preventive Vaccines Market by Administration, 2022-2032, $ mn 98

Table 26. South Korea Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 100

Table 27. South Korea Preventive Vaccines Market by Disease, 2022-2032, $ mn 100

Table 28. South Korea Preventive Vaccines Market by Administration, 2022-2032, $ mn 101

Table 29. Preventive Vaccines Market in Rest of APAC by Country/Region, 2022-2032, $ mn 103

Table 30. AstraZeneca plc: Company Snapshot 108

Table 31. AstraZeneca plc: Business Segmentation 109

Table 32. AstraZeneca plc: Product Portfolio 109

Table 33. Bavarian Nordic A/S: Company Snapshot 110

Table 34. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020 111

Table 35. China National Biotec Group Company Ltd.: Company Snapshot 113

Table 36. CSL Ltd.: Company Snapshot 115

Table 37. Daiichi Sankyo Co. Ltd.: Company Snapshot 117

Table 38. Emergent BioSolutions Inc.: Company Snapshot 119

Table 39. GlaxoSmithKline: Company Snapshot 121

Table 40. GlaxoSmithKline: Business Segmentation 122

Table 41. GlaxoSmithKline: Product Portfolio 123

Table 42. GlaxoSmithKline: Revenue, 2018-2020, $ bn 124

Table 43. GlaxoSmithKline: Recent Developments 124

Table 44. Johnson & Johnson: Company Snapshot 125

Table 45. Johnson & Johnson: Business Segments 126

Table 46. Merck & Co., Inc.: Company Snapshot 127

Table 47. Merck & Co., Inc.: Business Segmentation 127

Table 48. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 128

Table 49. Moderna Inc.: Company Snapshot 129

Table 50. Novavax, Inc.: Company Snapshot 130

Table 51. Pfizer Inc.: Company Snapshot 132

Table 52. Pfizer Inc.: Business Segmentation 133

Table 53. Pfizer Inc.: Product Portfolio 134

Table 54. Pfizer Inc.: Revenue, 2018-2020, $ bn 135

Table 55. Pfizer Inc.: Recent Developments 135

Table 56. Sanofi: Company Snapshot 136

Table 57. Sanofi: Business Segmentation 136

Table 58. Sanofi: Revenue, 2018-2020, $ bn 138

Table 59. Takeda Pharmaceutical Co. Ltd.: Company Snapshot 139


List of Figures:

Figure 1. Research Method Flow Chart 12

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 17

Figure 4. Asia Pacific Preventive Vaccines Market, 2022-2032, $ mn 20

Figure 5. Development Stages of Preventive Vaccines 21

Figure 6. Impact of COVID-19 on Business 25

Figure 7. Primary Drivers and Impact Factors of Asia Pacific Preventive Vaccines Market 31

Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 34

Figure 9. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 35

Figure 11. Primary Restraints and Impact Factors of Asia Pacific Preventive Vaccines Market 37

Figure 12. Investment Opportunity Analysis 41

Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Preventive Vaccines Market 44

Figure 14. Breakdown of Asia Pacific Preventive Vaccines Market by Vaccine Type, 2022-2032, % of Revenue 49

Figure 15. Asia Pacific Addressable Market Cap in 2023-2032 by Vaccine Type, Value ($ mn) and Share (%) 49

Figure 16. Asia Pacific Preventive Vaccines Market by Vaccine Type: Live/Attenuated Vaccines, 2022-2032, $ mn 50

Figure 17. Asia Pacific Preventive Vaccines Market by Vaccine Type: Inactivated Vaccines, 2022-2032, $ mn 51

Figure 18. Asia Pacific Preventive Vaccines Market by Vaccine Type: Subunit Vaccines, 2022-2032, $ mn 52

Figure 19. Asia Pacific Preventive Vaccines Market by Vaccine Type: Toxoid Vaccines, 2022-2032, $ mn 53

Figure 20. Asia Pacific Preventive Vaccines Market by Vaccine Type: Conjugate Vaccines, 2022-2032, $ mn 54

Figure 21. Asia Pacific Preventive Vaccines Market by Vaccine Type: mRNA Vaccines, 2022-2032, $ mn 55

Figure 22. Asia Pacific Preventive Vaccines Market by Vaccine Type: Recombinant Vector Vaccines, 2022-2032, $ mn 56

Figure 23. Asia Pacific Preventive Vaccines Market by Vaccine Type: Other Vaccines, 2022-2032, $ mn 57

Figure 24. Breakdown of Asia Pacific Preventive Vaccines Market by Disease, 2022-2032, % of Sales Revenue 59

Figure 25. Asia Pacific Addressable Market Cap in 2023-2032 by Disease, Value ($ mn) and Share (%) 59

Figure 26. Asia Pacific Preventive Vaccines Market by Disease: Pneumococcal Disease, 2022-2032, $ mn 60

Figure 27. Asia Pacific Preventive Vaccines Market by Disease: Poliovirus, 2022-2032, $ mn 61

Figure 28. Asia Pacific Preventive Vaccines Market by Disease: Hepatitis, 2022-2032, $ mn 62

Figure 29. Asia Pacific Preventive Vaccines Market by Disease: Influenza, 2022-2032, $ mn 63

Figure 30. Asia Pacific Preventive Vaccines Market by Disease: Measles, Mumps, and Rubella (MMR), 2022-2032, $ mn 64

Figure 31. Asia Pacific Preventive Vaccines Market by Disease: Varicella, 2022-2032, $ mn 65

Figure 32. Asia Pacific Preventive Vaccines Market by Disease: Human Papilloma Virus, 2022-2032, $ mn 66

Figure 33. Asia Pacific Preventive Vaccines Market by Disease: COVID-19, 2022-2032, $ mn 67

Figure 34. Asia Pacific Preventive Vaccines Market by Disease: Other Diseases, 2022-2032, $ mn 68

Figure 35. Breakdown of Asia Pacific Preventive Vaccines Market by Administration, 2022-2032, % of Sales Revenue 70

Figure 36. Asia Pacific Addressable Market Cap in 2023-2032 by Administration, Value ($ mn) and Share (%) 70

Figure 37. Asia Pacific Preventive Vaccines Market by Administration: Intramuscular Route, 2022-2032, $ mn 71

Figure 38. Asia Pacific Preventive Vaccines Market by Administration: Subcutaneous Route, 2022-2032, $ mn 72

Figure 39. Asia Pacific Preventive Vaccines Market by Administration: Oral Route, 2022-2032, $ mn 73

Figure 40. Asia Pacific Preventive Vaccines Market by Administration: Intravenous Injection, 2022-2032, $ mn 74

Figure 41. Asia Pacific Preventive Vaccines Market by Administration: Other Administration Routes, 2022-2032, $ mn 75

Figure 42. Breakdown of Asia Pacific Preventive Vaccines Market by Patient, 2022-2032, % of Revenue 77

Figure 43. Asia Pacific Addressable Market Cap in 2023-2032 by Patient, Value ($ mn) and Share (%) 77

Figure 44. Asia Pacific Preventive Vaccines Market by Patient: Pediatric Vaccines, 2022-2032, $ mn 78

Figure 45. Asia Pacific Preventive Vaccines Market by Patient: Adult Vaccines, 2022-2032, $ mn 80

Figure 46. Breakdown of APAC Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 83

Figure 47. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 84

Figure 48. Preventive Vaccines Market in Japan, 2022-2032, $ mn 86

Figure 49. Preventive Vaccines Market in China, 2022-2032, $ mn 89

Figure 50. Preventive Vaccines Market in Australia, 2022-2032, $ mn 93

Figure 51. Preventive Vaccines Market in India, 2022-2032, $ mn 96

Figure 52. Preventive Vaccines Market in South Korea, 2022-2032, $ mn 99

Figure 53. Preventive Vaccines Market in Rest of APAC, 2022-2032, $ mn 102

Figure 54. Growth Stage of Asia Pacific Preventive Vaccines Industry over the Forecast Period 104

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)